Biotech entity
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Henrietta Lacks, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Ben Crump, all published on February 27, 2026.
Last mentioned: Feb 27, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention Henrietta Lacks, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Ben Crump, all published on February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 17 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ben Crump. Shared-story counts are live from our verified record — not editorial picks.
Novartis Settlement
Novartis announces a confidential settlement with the Henrietta Lacks estate.
Ultragenyx Settlement
Ultragenyx settles with the estate over HeLa cell usage in gene therapy research.
Thermo Fisher Settlement
Thermo Fisher Scientific reaches a historic settlement with the Lacks family.
First Major Lawsuit
The Lacks estate files its first major lawsuit against Thermo Fisher Scientific.
Mass Production
HeLa cells are mass-produced and distributed globally, becoming a cornerstone of modern research.
Cells Harvested
Henrietta Lacks' cells are harvested without consent during cancer treatment at Johns Hopkins.
Novartis has reached a confidential settlement with the estate of Henrietta Lacks, ending litigation over the unauthorized use of her 'immortal' HeLa cells. This marks the latest in a series of legal victories for the Lacks family against pharmaceutical giants that profited from cells taken without consent in 1951.
Ben Crump is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
